Roivant Sciences Ltd (ROIV) Company Profile & Statistics

Roivant Sciences Ltd
ROIV
(Nasdaq - US)
Closed
11.21
-0.43 (-3.74%)
in:usd•As of: Nov 15, 2024 15:59 UTC -5
Pre Market:0+0.00 (0.00%)
Open
11.59
High
11.61
Low
11.14

About Roivant Sciences Ltd

CEO

Matthew Gline

Headquarters

7th floor 50 broadway

london, x0 sw1h 0db, united kingdom

Auditor

Ernst & Young LLP

Employees

908

Share Holders

Website

https://roivant.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Roivant Sciences is a biopharmaceutical company dedicated to improving the delivery of healthcare to patients. Roivant Sciences, formerly known as Montes Archimedes Acquisition Corp., is based in NEW YORK.

Roivant Sciences Ltd Statistics

Valuation Measures

Market Capitalization ²	8.29B
Enterprise Value	2.93B
Enterprise Value/EBITDA (ttm)	0.66
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	1.48
Price to Sales (ttm)	65.90
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	89.71%
Operating Margin (ttm)	-714.39%
Profit Margin (ttm)	3137.95%
Return on Equity (ttm)	-14.65%
Return on Invested Capital (ttm)	51.56%
Return on Assets (ttm)	-13.19%

Income Statement

Revenue (ttm)	158.30M
Revenue Per Share (ttm)	0.21
Gross Profit (ttm)	142.98M
EBITDA (ttm)³	4.42B
Net Income Avi to Common (ttm)	4.74B
Diluted EPS (ttm)	5.65

Share Statistics

Beta (5Y Monthly)	1.24
52-Week Change	27.33%
S&P500 52-Week Change	29.10%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	739.52M
Dividend Yield	0.00%
Float ⁴	681.10M
% Held by Insiders	7.90%
% Held by Institutions	64.76%

Balance Sheet

Total Cash (mrq)	5.68B
Total Cash Per Share (mrq)	7.68
Total Debt (mrq)	323.72M
Total Debt/Equity (mrq)	5.49%
Current Ratio (mrq)	27.91%
Quick Ratio (mrq)	27.91%
Book Value Per Share (mrq)	7.98

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.25
Free Cash Flow (ytd)	-193.79M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Roivant Sciences Ltd

Trade With A Regulated Broker